Evidence map›Paper›PMID 42099830›Full record

ArticleClinical hematology international2026

Bladder mass following bone marrow transplant for sickle cell disease: A diagnostic dilemma.

Yusuf Adelabu, Ugonna O Fakile, Wale Q Oladimeji, Kayode Oseni, Moses A Ogunjimi, Titilayo G Bamigboye, Blessing N Aziken-John, Amina Enegbuma, Zainab Olayiwola, Olufunto Kalejaiye and 6 more

Abstract readCase Reports
In one paragraph

Article in Clinical hematology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yusuf AdelabuLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Ugonna O FakileLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Wale Q OladimejiLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Kayode OseniLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Moses A OgunjimiLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Titilayo G BamigboyeLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Blessing N Aziken-JohnLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Amina EnegbumaLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Zainab OlayiwolaLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Olufunto KalejaiyeLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Titilope A AdeyemoLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Ann OgbennaLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Karina WilkersonDepartment of Medicine, Division of Hematology/Oncology, Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.
Edamisan TemiyeLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Adeseye M AkinseteLagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria.
Adetola A KassimDepartment of Medicine, Division of Hematology/Oncology, Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville, TN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematuria is a common sign of kidney and urinary tract issues in sickle cell disease (SCD). Hematopoietic stem cell transplantation (HSCT) can cure SCD but may also be complicated by conditions that cause hematuria. We report a case of painless hematuria caused by a bladder mass in a young woman after allogeneic HSCT for SCD. Further evaluation showed a friable pseudotumor of the bladder, which was deemed benign based on histological examination. The hematuria resolved with continuous bladder irrigation and cauterization of the bleeding mass. This case highlights that hematuria can originate from hidden pre-existing bladder lesions in the post-transplant setting.

Indexed as

bladder massbone marrow transplantationhematuriainflammatory pseudotumorSickle cell disease

Identifiers

PMID42099830
PMCPMC13148722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.